Changing Treatment Landscape of Eye Diseases: Dry Eye Disease, Ocular Surface Disease, Cataract Surgery, Neurotrophic Keratitis, and DAVS

Accredited Providers

This activity is jointly provided by Amedco and MedNet.

  

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and MedNet LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco Joint Accreditation Provider Number: 4008163

Physicians Credit Designation

Amedco designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Credit Information

Note to Physician Assistants

PAs may claim a maximum of 2.50 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit^TM from organizations accredited by ACCME or a recognized state medical society.

Note to Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allows reciprocity for AANPCP continuing education credit. 

Through an agreement between the American Medical Association (AMA) and the European Union of Medical Specialists, physicians and healthcare providers may convert CME/CE AMA PRA Category 1 Credits^TM to an equivalent number of European CME Credits^® (ECMECs^®). The UEMS-EACCME^® has recognition agreements with the AMA for live events and e-learning materials.

Conflicts of Interest Disclosure Policy

Amedco and MedNet adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME/CE activity, including faculty, planners, reviewers, or others are required to disclose all financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

The following table of disclosure information is provided to learners and contains the relevant financial relationships that each individual in a position to control the content disclosed to Amedco. All of these relationships were treated as a conflict of interest, and have been resolved. (C7 SCS 6.1-6.2, 6.5).

All individuals in a position to control the content of CE are listed below.
Beeran Meghpara, MD
Kishan G. Patel, MD
Stephen Pflugfelder, MD
William Waldrop, MD

Accredited Provider Disclosures

Amedco staff have no relevant financial relationships to disclose.

Planners’ and Managers’ Disclosures

MedNet staff have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a clinician relative to diagnostic and treatment options for a specific patient’s medical condition.

Disclaimer

The opinions expressed in this enduring material are those of the faculty and do not necessarily represent the views of Amedco, MedNet, and Alcon Vision, LLC.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

If you have any questions relating to the accreditation of this activity, please contact certificate@amedcoemail.com.